bluebird bio shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and multiple firms lowered their respective price targets on the stock.
Portfolio Pulse from Benzinga Newsdesk
bluebird bio shares are trading lower after JP Morgan downgraded the stock from Overweight to Neutral and multiple firms lowered their respective price targets on the stock.

August 15, 2024 | 7:49 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
bluebird bio shares are trading lower due to a downgrade from JP Morgan from Overweight to Neutral, along with multiple firms lowering their price targets.
The downgrade from a major financial institution like JP Morgan, combined with multiple firms lowering their price targets, is likely to negatively impact investor sentiment and lead to a short-term decline in bluebird bio's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100